Could brain zaps curb meth cravings? new trial investigates

NCT ID NCT06320366

Recruiting now Disease control Sponsor: University of Colorado, Denver Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an accelerated form of Transcranial Magnetic Stimulation (TMS) can help people with moderate to severe methamphetamine use disorder. Twenty participants will receive either real or sham TMS to the brain's prefrontal cortex. Researchers will check if the treatment is safe, tolerable, and reduces drug use and cravings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Transcranial Magnetic Stimulation (TMS) device
What this could lead to: If it works, this could offer a new, non-drug treatment to help people with methamphetamine use disorder reduce cravings and stay abstinent.
What could go wrong: This is a very small early-stage trial with only 20 participants, so results may not apply widely. The treatment is still experimental and may not reduce drug use more than a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METHAMPHETAMINE USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

methamphetamine dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METHAMPHETAMINE USE DISORDER

Contacts and locations

Locations

University of Colorado Anschutz Medical Campus
RECRUITING

Aurora, Colorado, 80045, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.